Julia Appelskog | Head of QPPV Office and PV Intelligence
CSL

Dr. Julia Appelskog is a seasoned pharmacovigilance expert and EU QPPV, currently heading the QPPV Office at Novavax. With over 22 years of experience in PV, quality assurance, and regulatory operations, she has led global PV teams at Bluefish Pharmaceuticals, TFS, and Merck and managed Nordic PV Hubs at MSD, J&J, and Sanofi Pasteur MSD. A PhD in cell biology from the Karolinska Institute, Dr. Appelskog is also an accomplished researcher in cancer and diabetes and has contributed extensively to EMA, EFPIA, and industry PV groups. She is the author of two influential books on AI in pharmacovigilance and drug safety.